CORC  > 武汉大学
Current Advances in Immunotherapy for Acute Leukemia: An Overview of Antibody, Chimeric Antigen Receptor, Immune Checkpoint, and Natural Killer
Shang, Yufeng; Zhou, Fuling
刊名FRONTIERS IN ONCOLOGY
2019
卷号9
关键词immunotherapy acute myeloid leukemia acute lymphoblastic leukemia antibody-drug conjugate bispecific antibody chimeric antigen receptor immune checkpoint
ISSN号2234-943X
DOI10.3389/fonc.2019.00917
URL标识查看原文
收录类别SCIE
语种英语
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4263081
专题武汉大学
推荐引用方式
GB/T 7714
Shang, Yufeng,Zhou, Fuling. Current Advances in Immunotherapy for Acute Leukemia: An Overview of Antibody, Chimeric Antigen Receptor, Immune Checkpoint, and Natural Killer[J]. FRONTIERS IN ONCOLOGY,2019,9.
APA Shang, Yufeng,&Zhou, Fuling.(2019).Current Advances in Immunotherapy for Acute Leukemia: An Overview of Antibody, Chimeric Antigen Receptor, Immune Checkpoint, and Natural Killer.FRONTIERS IN ONCOLOGY,9.
MLA Shang, Yufeng,et al."Current Advances in Immunotherapy for Acute Leukemia: An Overview of Antibody, Chimeric Antigen Receptor, Immune Checkpoint, and Natural Killer".FRONTIERS IN ONCOLOGY 9(2019).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace